Format

Send to

Choose Destination
Respiration. 2016;91(4):333-48. doi: 10.1159/000444088. Epub 2016 Mar 5.

Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients.

Author information

1
School of Pharmaceutical Sciences, University of Geneva and University of Lausanne, Geneva, Switzerland.

Abstract

Health management of cystic fibrosis (CF) patients should be maximized during pregnancy and breastfeeding because of its significant impact on the maternal and newborn outcomes. Thus, numerous drugs will have to be continued during pregnancy and lactation. Most of the drugs representing CF treatment lines cross the placenta or are excreted into human milk. Research addressing the risks and benefits of drugs used in CF patients during pregnancy and lactation is often incomplete or challenged by limited methodology, which often leads to conflicting or inconclusive results. Yet, potential treatment benefits for CF pregnant patients most often outbalance potential risks for the unborn child.

PMID:
26942733
DOI:
10.1159/000444088
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center